Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pembrolizumab for locally advanced cervical cancer.
Schmid MP, Petric P, Mahantshetty U, Kirisits C, Tanderup K, Jürgenliemk-Schulz I, Lindegaard J, Pötter R. Schmid MP, et al. Among authors: kirisits c. Lancet. 2024 Nov 23;404(10467):2050-2051. doi: 10.1016/S0140-6736(24)02231-1. Lancet. 2024. PMID: 39580199 No abstract available.
Uncertainty Quantification for Scale-Space Blob Detection.
Parzer F, Kirisits C, Scherzer O. Parzer F, et al. Among authors: kirisits c. J Math Imaging Vis. 2024;66(4):697-717. doi: 10.1007/s10851-024-01194-x. Epub 2024 May 23. J Math Imaging Vis. 2024. PMID: 39156696 Free PMC article.
Are we making progress in curing advanced cervical cancer-again?
Lindegaard JC, Petric P, Tan LT, Hoskin P, Schmid MP, Jürgenliemk-Schulz I, Mahantshetty U, Kirisits C, Pötter R. Lindegaard JC, et al. Among authors: kirisits c. Int J Gynecol Cancer. 2024 Aug 24:ijgc-2024-005572. doi: 10.1136/ijgc-2024-005572. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38986568 Review.
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost.
Moll M, Magrowski Ł, Mittlböck M, Heinzl H, Kirisits C, Ciepał J, Masri O, Heilemann G, Stando R, Krzysztofiak T, Depowska G, d'Amico A, Techmański T, Kozub A, Majewski W, Suwiński R, Wojcieszek P, Sadowski J, Widder J, Goldner G, Miszczyk M. Moll M, et al. Among authors: kirisits c. Strahlenther Onkol. 2024 Jun 3. doi: 10.1007/s00066-024-02245-3. Online ahead of print. Strahlenther Onkol. 2024. PMID: 38829436
Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients.
Moll M, Nechvile E, Kirisits C, Komina O, Pajer T, Kohl B, Miszczyk M, Widder J, Knocke-Abulesz TH, Goldner G. Moll M, et al. Among authors: kirisits c. Strahlenther Onkol. 2024 Aug;200(8):698-705. doi: 10.1007/s00066-024-02222-w. Epub 2024 Mar 15. Strahlenther Onkol. 2024. PMID: 38488901 Free PMC article.
EviGUIDE - a tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer.
Ecker S, Kirisits C, Schmid M, Knoth J, Heilemann G, De Leeuw A, Sturdza A, Kirchheiner K, Jensen N, Nout R, Jürgenliemk-Schulz I, Pötter R, Spampinato S, Tanderup K, Eder-Nesvacil N. Ecker S, et al. Among authors: kirisits c. Radiother Oncol. 2023 Sep;186:109748. doi: 10.1016/j.radonc.2023.109748. Epub 2023 Jun 16. Radiother Oncol. 2023. PMID: 37330055 Free article.
Brachytherapy boost in anal canal cancer - A GEC ESTRO PDR task force meta-analysis.
Annede P, Ferre M, Kirisits C, Pieters BR, Schmid M, Strnad V, Westerveld H, Chargari C. Annede P, et al. Among authors: kirisits c. Clin Transl Radiat Oncol. 2023 Jan 30;39:100589. doi: 10.1016/j.ctro.2023.100589. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2023. PMID: 36785565 Free PMC article.
184 results